| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1160/TH04-12-0842 |
| P698 | PubMed publication ID | 15841308 |
| P50 | author | Francis J Castellino | Q96229305 |
| Victoria Ploplis | Q105826433 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 647-654 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
| P1476 | title | Structure and function of the plasminogen/plasmin system | |
| P478 | volume | 93 |
| Q61448811 | A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis |
| Q34808641 | A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events |
| Q90231776 | A critical role for plasminogen in inflammation |
| Q35559411 | A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction |
| Q80228171 | A new role for NF-kappaB in angiogenesis inhibition |
| Q82637377 | A new series of the SMTP plasminogen modulator with a phenylglycine-based side chain |
| Q83914923 | A new series of the SMTP plasminogen modulators with a phenylamine-based side chain |
| Q46635176 | A study of cutaneous lesions caused by Leishmania mexicana in plasminogen-deficient mice |
| Q39250587 | Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA. |
| Q42914615 | Activators and inhibitors of the plasminogen system in Alzheimer's disease. |
| Q58606295 | Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications |
| Q90030308 | An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1 |
| Q35169853 | Analysis of Paracoccidioides secreted proteins reveals fructose 1,6-bisphosphate aldolase as a plasminogen-binding protein |
| Q39367074 | Angiogenesis and Proteinases: Influence on Vascular Morphogenesis, Stabilization and Regression |
| Q33222336 | Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice |
| Q36337574 | Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination |
| Q38057217 | Bacterial plasminogen receptors: mediators of a multifaceted relationship. |
| Q39479495 | Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells |
| Q58041426 | Beyond hemostasis: the challenge of treating plasminogen deficiency. A report of three cases |
| Q38669149 | Biophysical Mechanisms Mediating Fibrin Fiber Lysis. |
| Q81962689 | Blood coagulation and fibrinolysis: mechanisms of thrombosis |
| Q26781646 | Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface |
| Q24337821 | CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation |
| Q38055477 | Cell surface remodeling by plasmin: a new function for an old enzyme |
| Q55239975 | Changed Expression of Cytoskeleton Proteins During Lung Injury in a Mouse Model of Streptococcus pneumoniae Infection. |
| Q36480477 | Curli biogenesis and function |
| Q57285296 | Curli-Containing Enteric Biofilms Inside and Out: Matrix Composition, Immune Recognition, and Disease Implications |
| Q35887881 | Data supporting the structural and functional characterization of Thrombin-Activatable Fibrinolysis Inhibitor in breast cancer |
| Q39067705 | Deciphering Key Residues Involved in the Virulence-promoting Interactions between Streptococcus pneumoniae and Human Plasminogen |
| Q35079577 | Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain. |
| Q35883913 | Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein |
| Q27644557 | Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein–Protein Interaction |
| Q34413457 | Disease manifestations and pathogenic mechanisms of Group A Streptococcus |
| Q36080505 | Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells |
| Q37409534 | Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis |
| Q33759211 | Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM). |
| Q28476949 | Eimeria species and genetic background influence the serum protein profile of broilers with coccidiosis |
| Q86450783 | Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome |
| Q35586122 | Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi |
| Q35042660 | Engineering streptokinase for generation of active site-labeled plasminogen analogs |
| Q34324817 | Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice |
| Q34975047 | Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target. |
| Q88576022 | Excessive Plasmin Compromises Hepatic Sinusoidal Vascular Integrity After Acetaminophen Overdose |
| Q38456535 | Exploitation of plasmin(ogen) by bacterial pathogens of veterinary significance |
| Q33244333 | Expression of angiostatin cDNA in human gallbladder carcinoma cell line GBC-SD and its effect on endothelial proliferation and growth |
| Q52606339 | Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. |
| Q64937348 | Fibrinolysis and Inflammation in Venous Thrombus Resolution. |
| Q91763569 | Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines |
| Q38269342 | From plasminogen to plasmin: role of plasminogen receptors in human cancer. |
| Q30372842 | Genetically determined proteolytic cleavage modulates alpha7beta1 integrin function. |
| Q37100544 | How is plasminogen/plasmin system contributing to regulate sperm entry into the oocyte? |
| Q41928116 | Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6. |
| Q33822542 | Impaired fibrinolysis in the antiphospholipid syndrome |
| Q42422328 | Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema |
| Q50716839 | Lack of plasminogen leads to milk stasis and premature mammary gland involution during lactation. |
| Q91793774 | Ligneous Periodontitis in a Patient with Type 1 Plasminogen Deficiency: A Case Report and Review of the Literature |
| Q48188580 | Markers of inflammation and fibrinolysis in relation to outcome after surgery for lumbar disc herniation. A prospective study on 177 patients |
| Q24337459 | Melanotransferrin stimulates t-PA-dependent activation of plasminogen in endothelial cells leading to cell detachment |
| Q34510846 | Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations |
| Q91729291 | Molecular characterization of a Trichinella spiralis enolase and its interaction with the host's plasminogen |
| Q35164287 | Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen |
| Q99418171 | Multi-omic studies on missense PLG variants in families with otitis media |
| Q37088045 | NF-kappa B: a new player in angiostatic therapy |
| Q37981959 | New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis |
| Q33768031 | New insights into the role of Plg-RKT in macrophage recruitment |
| Q37356686 | New insights into the role of brain-derived neurotrophic factor in synaptic plasticity |
| Q37115034 | Novel actions of tissue-type plasminogen activator in chronic kidney disease |
| Q30482426 | Nuclear translocation of urokinase-type plasminogen activator |
| Q91676502 | Numerous Fasciola plasminogen-binding proteins may underlie blood-brain barrier leakage and explain neurological disorder complexity and heterogeneity in the acute and chronic phases of human fascioliasis |
| Q61446738 | Origin and diversification of the plasminogen activation system among chordates |
| Q36940906 | Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis |
| Q35905628 | Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction |
| Q34119378 | Paracoccidioides brasiliensis enolase is a surface protein that binds plasminogen and mediates interaction of yeast forms with host cells |
| Q38704015 | Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors |
| Q35032037 | Photonic activation of plasminogen induced by low dose UVB. |
| Q41174665 | Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis |
| Q90058442 | Plasmin improves oedematous blood-gas barrier by cleaving epithelial sodium channels |
| Q42124151 | Plasmin is essential in preventing periodontitis in mice |
| Q89776548 | Plasmin-mediated proteolysis of human factor IXa in the presence of calcium/phospholipid: Conversion of procoagulant factor IXa to a fibrinolytic enhancer |
| Q33884423 | Plasminogen Tochigi mice exhibit phenotypes similar to wild-type mice under experimental thrombotic conditions |
| Q90606599 | Plasminogen is a master regulator and a potential drug candidate for the healing of radiation wounds |
| Q36013653 | Plasminogen is an important regulator in the pathogenesis of a murine model of asthma |
| Q46947348 | Plasminogen potentiates thrombin cytotoxicity and contributes to pathology of intracerebral hemorrhage in rats |
| Q37609916 | Plasminogen receptors: the first quarter century |
| Q50102258 | Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency |
| Q34467715 | Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis |
| Q35783075 | Porphyromonas gingivalis-derived RgpA-Kgp Complex Activates the Macrophage Urokinase Plasminogen Activator System: IMPLICATIONS FOR PERIODONTITIS |
| Q42683497 | Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution. |
| Q33758094 | Probing binding and cellular activity of pyrrolidinone and piperidinone small molecules targeting the urokinase receptor |
| Q36949037 | Prothrombotic effects of thrombolytic therapy in a rat (Rattus norvegicus) model of venous thrombolysis |
| Q42166965 | Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia |
| Q33480978 | Reduction of canine plasminogen leads to an expanded molecule which precipitates |
| Q34562488 | Regulation of MMP2 and MMP9 metalloproteinases by FSH and growth factors in bovine granulosa cells |
| Q37660895 | Regulation of cell signalling by uPAR. |
| Q88739316 | Regulation of plasminogen activation on cell surfaces and fibrin |
| Q35142158 | Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9 |
| Q27692619 | Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing. |
| Q24293140 | Residues essential for plasminogen binding by the cation-independent mannose 6-phosphate receptor |
| Q37189305 | Revisiting the biological roles of PAI2 (SERPINB2) in cancer |
| Q99565518 | Roles of fibrinolytic factors in the alterations in bone marrow hematopoietic stem/progenitor cells during bone repair |
| Q41958435 | SMTP (Stachybotrys microspora triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats |
| Q82261993 | SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels |
| Q37394744 | Sculpting the blank slate: how fibrin's support of vascularization can inspire biomaterial design |
| Q36003719 | Streptococcus uberis plasminogen activator (SUPA) activates human plasminogen through novel species-specific and fibrin-targeted mechanisms |
| Q92277771 | Structural Biology and Protein Engineering of Thrombolytics |
| Q41923457 | Support vector machine (SVM) based multiclass prediction with basic statistical analysis of plasminogen activators |
| Q34163191 | Targeted thrombolysis strategies for neuroprotective effect |
| Q37695366 | That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins |
| Q26741286 | The Expanding Landscape of Moonlighting Proteins in Yeasts |
| Q64076093 | The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer |
| Q38927516 | The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin. |
| Q37401343 | The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia |
| Q35500642 | The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice |
| Q49817123 | The clinical value of soluble urokinase plasminogen activation receptor in febrile neutropenic patients with hematological malignancies after chemotherapy |
| Q38803641 | The evolution of recombinant thrombolytics: Current status and future directions |
| Q34249848 | The generation and characterization of mice expressing a plasmin-inactivating active site mutation |
| Q37817023 | The plasmin-antiplasmin system: structural and functional aspects |
| Q36228900 | The plasminogen activator system modulates sympathetic nerve function. |
| Q58698635 | The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci |
| Q104459005 | The plasminogen receptor, Plg-RKT, plays a role in inflammation and fibrinolysis during cutaneous wound healing in mice |
| Q38057219 | The plasminogen system in regulating stem cell mobilization |
| Q38202723 | The porcine innate immune system: an update |
| Q90171163 | Therapeutics targeting the fibrinolytic system |
| Q38099731 | Three are better than one: plasminogen receptors as cancer theranostic targets. |
| Q28246124 | Thrombin and vascular inflammation |
| Q37419812 | Thrombolytic therapy for deep vein thrombosis: potential application of plasmin |
| Q34202920 | Tissue plasminogen activator and plasminogen activator inhibitor 1 contribute to sonic hedgehog-induced in vitro cerebral angiogenesis |
| Q92059092 | Tissue-type plasminogen activator-primed human iPSC-derived neural progenitor cells promote motor recovery after severe spinal cord injury |
| Q51731919 | Total urokinase-type plasminogen activator (uPA) levels in seminal plasma are associated with positive assisted reproductive technology outcomes. |
| Q33691725 | Tranexamic acid-induced ligneous conjunctivitis with renal failure showed reversible hypoplasminogenaemia |
| Q36832462 | Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis |
| Q39736356 | Urokinase-type plasminogen activator induces BV-2 microglial cell migration through activation of matrix metalloproteinase-9. |
| Q90258614 | tPA promotes the proliferation of lung fibroblasts and activates the Wnt/β-catenin signaling pathway in idiopathic pulmonary fibrosis |
Search more.